Literature DB >> 23916565

Clinical characteristics of central diabetes insipidus in Taiwanese children.

Shih-Yao Liu1, Yi-Ching Tung, Cheng-Ting Lee, Hon-Man Liu, Shinn-Forng Peng, Mu-Zon Wu, Meng-Fai Kuo, Wen-Yu Tsai.   

Abstract

BACKGROUND/
PURPOSE: Data on the clinical features of children with central diabetes insipidus (CDI) are lacking in Taiwan. This study investigated the clinical manifestations and etiology of CDI in Taiwanese children.
METHODS: From 1983 to 2012, 62 children with permanent diabetes insipidus were enrolled in the study. They were diagnosed at the Department of Pediatrics of National Taiwan University Hospital. Their medical records were thoroughly reviewed and their clinical symptoms and signs, laboratory data, and etiologies were analyzed.
RESULTS: The patients' median age at diagnosis was 10 years and the median interval between initial manifestations and diagnosis was 0.5 years. The most common symptoms and signs were polyuria, polydipsia, nocturia, and growth retardation. Most patients had low urine osmolality and elevated plasma osmolality on diagnosis. Absence of a posterior pituitary hyperintense signal and thickening of the pituitary stalk were common findings on magnetic resonance imaging. Approximately 80% of the patients had anterior pituitary hormone deficiency and all patients had growth hormone deficiency. Approximately 60% of patients had intracranial lesions, the most common causes of which were germ cell tumor and Langerhans cell histiocytosis. Two patients were initially believed to have idiopathic CDI but intracranial lesions were detected during the follow-up period.
CONCLUSION: Because a delayed diagnosis of CDI is common in Taiwanese children, a high index of suspicion is important. The underlying etiology of CDI in children may not initially be obvious. Long-term surveillance is therefore necessary, especially for the early detection of evolving treatable intracranial lesions.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Langerhans cell histiocytosis; central diabetes insipidus; germ cell tumor; hypopituitarism

Mesh:

Substances:

Year:  2013        PMID: 23916565     DOI: 10.1016/j.jfma.2013.06.019

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  5 in total

Review 1.  Pituitary Stalk Thickening: Causes and Consequences. The Children's Memorial Health Institute Experience and Literature Review.

Authors:  Elżbieta Moszczyńska; Karolina Kunecka; Marta Baszyńska-Wilk; Marta Perek-Polnik; Dorota Majak; Wiesława Grajkowska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-20       Impact factor: 6.055

Review 2.  Diabetes insipidus: The other diabetes.

Authors:  Sanjay Kalra; Abdul Hamid Zargar; Sunil M Jain; Bipin Sethi; Subhankar Chowdhury; Awadhesh Kumar Singh; Nihal Thomas; A G Unnikrishnan; Piya Ballani Thakkar; Harshad Malve
Journal:  Indian J Endocrinol Metab       Date:  2016 Jan-Feb

3.  Central Diabetes Insipidus in Children and Adolescents: Twenty-Six Year Experience from a Single Centre.

Authors:  Hüseyin Anil Korkmaz; Ritika R Kapoor; Jennifer Kalitsi; Simon Jb Aylwin; Charles R Buchanan; Ved Bhushan Arya
Journal:  Int J Endocrinol       Date:  2022-03-08       Impact factor: 3.257

4.  Pituitary Morphology and Function in 43 Children with Central Diabetes Insipidus.

Authors:  Wendong Liu; Limin Wang; Minghua Liu; Guimei Li
Journal:  Int J Endocrinol       Date:  2016-03-29       Impact factor: 3.257

5.  Clinical Characteristics of Pediatric Patients With Sellar and Suprasellar Lesions Who Initially Present With Central Diabetes Insipidus: A Retrospective Study of 55 Cases From a Large Pituitary Center in China.

Authors:  Xin Ji; Zihao Wang; Wenze Wang; Lu Gao; Xiaopeng Guo; Chenzhe Feng; Wei Lian; Kan Deng; Bing Xing
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-20       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.